Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury: Protective role of peroxisome proliferator-activated receptor-γ

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 1, 2014, Pages 85-97

  Li, Hong ^a   Singh, Sangya ^a   Potula, Raghava ^b   Persidsky, Yuri ^b   Kanmogne, Georgette D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV AIDS; Macrophages; PBMC; Pulmonary endothelium; Tight junction proteins

Indexed keywords

CLAUDIN 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PROTEIN ZO1; PROTEIN ZO2; ROSIGLITAZONE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; LUNG INJURY; LUNG PARENCHYMA; MACROPHAGE; MALE; MICROVASCULAR ENDOTHELIAL CELL; MICROVASCULATURE; MIDDLE AGED; MOUSE; NONHUMAN; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIREMIA;

HIV/AIDS; MACROPHAGES; PBMC; PULMONARY ENDOTHELIUM; TIGHT JUNCTION PROTEINS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANIMALS; BRONCHOPNEUMONIA; CASE-CONTROL STUDIES; CLAUDIN-5; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; LUNG; LUNG DISEASES, INTERSTITIAL; MACROPHAGES; MALE; MICE; MIDDLE AGED; PPAR GAMMA; TIGHT JUNCTION PROTEINS;

EID: 84903824151     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201106-1151OC     Document Type: Article

References (50)

1. Afessa B, Green W, Chiao J, Frederick W. Pulmonary complications of HIV infection: autopsy findings. Chest 1998;113: 1225-1229.
2. Lanjewar DN, Duggal R. Pulmonary pathology in patients with AIDS: an autopsy study from Mumbai. HIV Med 2001;2: 266-271.
3. Soeiro AdeM, Hovnanian AL, Parra ER, Canzian M, Capelozzi VL. Postmortem histological pulmonary analysis in patients with HIV/AIDS. Clinics (Sao Paulo) 2008;63: 497-502.
4. Agostini C, Sancetta R, Cerutti A, Semenzato G. Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease. J Leukoc Biol 1995;58: 495-500.
5. Griffiths MH, Miller RF, Semple SJ. Interstitial pneumonitis in patients infected with the human immunodeficiency virus. Thorax 1995;50: 1141-1146.
6. Chakraborty R, Pulver A, Pulver LS, Musoke R, Palakudy T, D'Agostino A, Rana F. The post-mortem pathology of HIV-1-infected African children. Ann Trop Paediatr 2002;22: 125-131.
7. Graham SM. HIV-related pulmonary disorders: practice issues. Ann Trop Paediatr 2007;27: 243-252.
8. Huang TH, Razmovski-Naumovski V, Kota BP, Lin DS, Roufogalis BD. The pathophysiological function of peroxisome proliferatoractivated receptor-gamma in lung-related diseases. Respir Res 2005;6: 102.
9. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF. Peroxisome proliferator-Activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 2003;92: 1162-1169.
10. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391: 82-86.
11. Ricote M, Valledor AF, Glass CK. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24: 230-239.
12. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, et al. Rosiglitazone, a ligand of the peroxisome proliferator-Activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol 2004;483: 79-93.
13. Skolnik PR, Rabbi MF, Mathys JM, Greenberg AS. Stimulation of peroxisome proliferator-Activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. J Acquir Immune Defic Syndr 2002;31: 1-10.
14. Huang W, Rha GB, Han MJ, Eum SY, Andrá s IE, Zhong Y, Hennig B, Toborek M. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J Neurochem 2008;107: 497-509.
15. Morita K, Sasaki H, Furuse M, Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999;147: 185-194.
16. Amasheh S, Milatz S, Krug SM, Markov AG, Günzel D, Amasheh M, Fromm M. Tight junction proteins as channel formers and barrier builders. Ann N Y Acad Sci 2009;1165: 211-219.
17. Piehl C, Piontek J, Cording J, Wolburg H, Blasig IE. Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules. Cell Mol Life Sci 2010;67: 2131-2140.
18. Ohtsuki S, Sato S, Yamaguchi H, Kamoi M, Asashima T, Terasaki T. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. J Cell Physiol 2007;210: 81-86.
19. Kaarteenaho R, Merikallio H, Lehtonen S, Harju T, Soini Y. Divergent expression of claudin -1, -3, -4, -5 and -7 in developing human lung. Respir Res 2010;11: 59.
20. Xia XM, Wang FY, Wang ZK, Wan HJ, Xu WA, Lu H. Emodin enhances alveolar epithelial barrier function in rats with experimental acute pancreatitis. World J Gastroenterol 2010;16: 2994-3001.
21. Li Q, Zhang Q, Wang C, Liu X, Qu L, Gu L, Li N, Li J. Altered distribution of tight junction proteins after intestinal ischaemia/reperfusion injury in rats. J Cell Mol Med 2009;13: 4061-4076.
22. Simon DM, Tsai LW, Ingenito EP, Starcher BC, Mariani TJ. PPARgamma deficiency results in reduced lung elastic recoil and abnormalities in airspace distribution. Respir Res 2010;11: 69.
23. Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 2008;111: 2062-2072.
24. Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HS, Epstein L, Gelbard H, et al. Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol 1996;149: 1027-1053. (see comments.).
25. Potula R, Ramirez SH, Knipe B, Leibhart J, Schall K, Heilman D, Morsey B, Mercer A, Papugani A, Dou H, et al. Peroxisome proliferatoractivated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis. AIDS 2008;22: 1539-1549.
26. Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H, Fujiwara S, Shimizu K, Honda M, Shimizu N, et al. Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 2007;81: 13259-13264.
27. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, et al. Hematopoietic stem cellengrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007;109: 212-218.
28. Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/-mice. J Virol 2007;81: 2700-2712.
29. Newman PJ. The role of PECAM-1 in vascular cell biology. Ann N Y Acad Sci 1994;714: 165-174.
30. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-Activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391: 79-82.
31. Liu D, Zeng BX, Shang Y. Decreased expression of peroxisome proliferator-Activated receptor gamma in endotoxin-induced acute lung injury. Physiol Res 2006;55: 291-299.
32. Standiford TJ, Keshamouni VG, Reddy RC. Peroxisome proliferatoractivated receptor-gamma as a regulator of lung inflammation and repair. Proc Am Thorac Soc 2005;2: 226-231.
33. Theron S, Andronikou S, George R, du Plessis J, Goussard P, Hayes M, Mapukata A, Gie R. Non-infective pulmonary disease in HIV-positive children. Pediatr Radiol 2009;39: 555-564.
34. Kanmogne GD, Kennedy RC, Grammas P. Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Res Hum Retroviruses 2001;17: 45-53.
35. Kanmogne GD, Primeaux C, Grammas P. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 2005;333: 1107-1115.
36. Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-Associated dementia. J Neuropathol Exp Neurol 2005;64: 498-505.
37. Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, et al. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease. Methods Mol Biol 2010;602: 105-117.
38. Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundam Clin Pharmacol 2006;20: 429-447.
39. Shrivastav S, Kino T, Cunningham T, Ichijo T, Schubert U, Heinklein P, Chrousos GP, Kopp JB. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-Activated receptor gamma and inhibits adipocyte differentiation: implications for HIV-Associated lipodystrophy. Mol Endocrinol 2008;22: 234-247.
40. Huang W, Eum SY, Andrá s IE, Hennig B, Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 2009;23: 1596-1606.
41. Crossno JT Jr, Garat CV, Reusch JE, Morris KG, Dempsey EC, McMurtry IF, Stenmark KR, Klemm DJ. Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 2007;292: L885-L897.
42. Rehan VK, Sakurai R, Corral J, Krebs M, Ibe B, Ihida-Stansbury K, Torday JS. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol 2010;299: L672-L680.
43. Aoki Y, Maeno T, Aoyagi K, Ueno M, Aoki F, Aoki N, Nakagawa J, Sando Y, Shimizu Y, Suga T, et al. Pioglitazone, a peroxisome proliferator-Activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis. Respiration 2009; 77: 311-319.
44. de Andrade JA, Thannickal VJ. Innovative approaches to the therapy of fibrosis. Curr Opin Rheumatol 2009;21: 649-655.
45. Liu D, Zeng BX, Shang Y. Decreased expression of peroxisome proliferator-Activated receptor gamma in endotoxin-induced acute lung injury. Physiol Res 2006;55: 291-299.
46. Liu D, Zeng BX, Zhang SH, Wang YL, Zeng L, Geng ZL, Zhang SF. Rosiglitazone, a peroxisome proliferator-Activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats. Crit Care Med 2005;33: 2309-2316.
47. Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, Kleeberger SR. Nrf2-regulated PPARgamma expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med 2010; 182: 170-182.
48. Asada K, Sasaki S, Suda T, Chida K, Nakamura H. Antiinflammatory roles of peroxisome proliferator-Activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med 2004;169: 195-200.
49. Malur A, Mccoy AJ, Arce S, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. J Immunol 2009;182: 5816-5822.
50. Chaudhuri A, Duan F, Morsey B, Persidsky Y, Kanmogne GD. HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of bloodbrain barrier dysfunction. J Cereb Blood Flow Metab 2008;28: 697-711.